Please login to the form below

Not currently logged in
Email:
Password:

Intercytex

This page shows the latest Intercytex news and features for those working in and with pharma, biotech and healthcare.

UK regenerative medicine projects get £8.5m boost

An £8.5m package of grants will be shared by 14 projects in development by companies that include Cell Medica, Intercytex and Lonza Biologics. ... The projects will be led by: Altrika, Asymptote, Cell Medica, CellSeed Europe, Cellzome, ImmunoSolv,

Latest news

  • Take off

    Turnover was zero. Intercytex uses the body's own repair mechanisms to slow down ageing. ... Intercytex has a skin replacement product for burns, and is aiming for this to replace skin grafts.

  • Merger mania hits

    The company uses human cells for its skin and hair replacement products - a market that Intercytex believes is worth some $6bn in sales. ... Intercytex currently has a venous leg ulcer treatment in phase III trials and expects to release further

  • Bright backdrop

    On the new listings AIM front, where a wave of biotech and healthcare companies are thought to be putting the final touches to their plans for a flotation, Intercytex, a

  • Up and up?

    Meanwhile, Intercytex, a firm is working on a treatment for baldness, hopes to raise around £15m through a floatation on AIM.

  • Weathering the storm

    Intercytex seeks backing for serious wound product. Intercytex, the speciality pharmaceutical and biotech firm, posted a pre-tax loss of £11.6m on sales up 34 per cent to £111, 000. ... The company's lead product is a treatment for serious wounds and

More from news
Approximately 0 fully matching, plus 7 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Hamell

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

Are you ready for the digital health revolution?
In this edition of Delta magazine, we explore how rapid digitalization has transformed the care pathway and reveal how life science companies can succeed in the digital age....
#DemandDiversity: Can new medical publication guidelines help fix diversity in clinical trials?
Over the last 8 months, JAMA have been working on a new set of guidelines for research papers looking to publish with them, which is summarised in their latest editorial...
DATA shutterstock_1818502577-640.jpg
Empowering patients empowers results
Patient-centricity is key when it comes to creating a more flexible, efficient and modern process for clinical trials...

Infographics